TLS to Sponsor Patients As Partners Europe Conference, January 23-24, London

CEO Tomasz Sablinski to Discuss Virtual Trials at 3rd Annual Clinical Trials Collaborations Conference, April 9-11, Boston

CEO Tomasz Sablinski to Conduct Remote Research Workshop at CNS Summit 2017, Nov 17, Boca Raton

Transparency Life Sciences Awarded U.S. Patent for Combined Protocol Crowdsourcing and Digital Data Collection Platform

COO Marc Foster to Attend "Mobile in Clinical Trials" Conference, Sept 6, Boston

CEO Tomasz Sablinski to Speak on Panel "How Digital Health Will Transform Rare Disease Clinical Trials" at 2017 RARE Patient Advocacy Summit, Sept 15, Irvine, CA

COO Marc Foster to Speak on "Combining Crowdsourced Protocol Design and Digital Study Execution" at CTTI’s Legal and Regulatory Issues in Mobile Clinical Trials Summit, July 11th, Silver Springs, MD

CEO Tomasz Sablinski to Speak on The Siteless Clinical Trial Model at Disrupting Clinical Trials Europe Conference, February 8, London

First Patient Enrolled in Lisinopril Calibration Study

Over the winter break, we enrolled our first patient into the calibration stage of the lisinopril in multiple sclerosis study. This initial stage of the trial is to validate the novel remote endpoint that we will use in the 100-patient, Phase 2 study. In designing this trial, we have adapted the Multiple Sclerosis Function Composite (MSFC) to be done from a patient's home or office via video chat. The examination consists of the participant completing a timed walk test, a dexterity peg test, and an mental arithmetic test.

COO Marc Foster to Speak on Panel "Electronic Data Capture in Clinical Trials Featuring Connected Devices" at 2nd Annual Clinical Trial & IoT Forum, November 7, Cambridge, MA


Subscribe to TLS RSS

Always stay in the loop.
Sign up for our newsletter for the latest project updates.